Heart rate variability is associated with haptoglobin phenotype in patients with coronary artery disease

被引:0
作者
Christensen, JH [1 ]
Krarup, HB
Riahi, S
Toft, E
Schmidt, EB
机构
[1] Aalborg Hosp, Dept Nephrol, DK-9100 Aalborg, Denmark
[2] Aalborg Hosp, Dept Clin Biochem, DK-9100 Aalborg, Denmark
[3] Aalborg Hosp, Dept Cardiol, DK-9100 Aalborg, Denmark
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2005年 / 12卷 / 03期
关键词
coronary artery disease; haptoglobin phenotype; heart rate variability; risk factors;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Three haptoglobin phenotypes exist called Hp 1-1, Hp 2-2, and Hp 2-1. Patients carrying the haptoglobin 1 allele seem to be partly protected against coronary artery disease. An attenuated heart rate variability is associated with a poor outcome in patients with coronary artery disease. Therefore, we hypothesized that the presence of the haptoglobin 1 allele would be associated with a favourable heart rate variability. Design A cross-sectional study. Methods We included 255 patients who were referred for elective coronary angiography as a result of suspected coronary artery disease, and all underwent 24-h electrocardiogram recordings to assess heart rate variability in the time domain. The haptoglobin phenotype was also determined in each patient. Results There were 159 patients in the Hp 1-1 and Hp 2-1 groups and 98 patients in the Hp 2-2 group. The two groups were comparable with respect to clinical parameters. However, the Hp 2-2 group had significantly lower 24-h heart rate variability values compared with the other group (RR 882 versus 921 ms, P=0.02; RMSSD 26 versus 30 ms, P < 0.01; pNN50 6 versus 9%, P=0.01). Furthermore, Hp 2-2 was independently and negatively associated with heart rate variability (P=0.02). Conclusion Hp 2-2 was associated with an attenuated heart rate variability in patients with coronary artery disease that may help to explain other results reporting a poor prognosis in Hp 2-2 patients. (c) 2005 The European Society of Cardiology.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 21 条
[1]  
Camm AJ, 1996, CIRCULATION, V93, P1043
[2]   EFFECT OF THE HAPTOGLOBIN PHENOTYPE ON THE SIZE OF A MYOCARDIAL INFARCT [J].
CHAPELLE, JP ;
ALBERT, A ;
SMEETS, JP ;
HEUSGHEM, C ;
KULBERTUS, HE .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (08) :457-463
[3]  
Christensen JH, 2003, DAN MED BULL, V50, P347
[4]   Haptoglobin polymorphism as a risk factor for coronary heart disease mortality [J].
De Bacquer, D ;
De Backer, G ;
Langlois, M ;
Delanghe, J ;
Kesteloot, H ;
Kornitzer, M .
ATHEROSCLEROSIS, 2001, 157 (01) :161-166
[5]   Fast determination of haptoglobin phenotype and calculation of hemoglobin binding capacity using high pressure gel permeation chromatography [J].
Delanghe, J ;
Allcock, K ;
Langlois, M ;
Claeys, L ;
De Buyzere, M .
CLINICA CHIMICA ACTA, 2000, 291 (01) :43-51
[6]   Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery [J].
Delanghe, J ;
Cambier, B ;
Langlois, M ;
DeBuyzere, M ;
Neels, H ;
DeBacquer, D ;
VanCauwelaert, P .
ATHEROSCLEROSIS, 1997, 132 (02) :215-219
[7]   SEVERITY OF CORONARY ATHEROSCLEROSIS CORRELATES WITH THE RESPIRATORY COMPONENT OF HEART-RATE-VARIABILITY [J].
HAYANO, J ;
YAMADA, A ;
MUKAI, S ;
SAKAKIBARA, Y ;
YAMADA, M ;
OHTE, N ;
HASHIMOTO, T ;
FUJINAMI, T ;
TAKATA, K .
AMERICAN HEART JOURNAL, 1991, 121 (04) :1070-1079
[8]   Haptoglobin phenotype and coronary artery collaterals in diabetic patients [J].
Hochberg, I ;
Roguin, A ;
Nikolsky, E ;
Chanderashekhar, PV ;
Cohen, S ;
Levy, AP .
ATHEROSCLEROSIS, 2002, 161 (02) :441-446
[9]   Heart rate variability and progression of coronary atherosclerosis [J].
Huikuri, HV ;
Jokinen, V ;
Syvänne, M ;
Nieminen, MS ;
Airaksinen, KEJ ;
Ikäheimo, MJ ;
Koistinen, JM ;
Kauma, H ;
Kesäniemi, AY ;
Majahalme, S ;
Niemelä, KO ;
Frick, MH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) :1979-1985
[10]  
KLEIGER R E, 1992, Cardiology Clinics, V10, P487